We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Expression of human dystrophin following the transplantation of genetically modified mdx myoblasts.
- Authors
Moisset, P-A; Gagnon, Y; Karpati, G; Tremblay, J P
- Abstract
Transplantation of genetically modified autologous myoblasts has been proposed as a possible solution to avoid long-term use of immunosuppressive drugs. To determine the conditions to be used in this kind of approach for possible treatment of dystrophin deficiency, mdx myoblasts were infected at different multiplicities of infection (MOI of 0.01–1000) with an adenoviral vector containing a CMV promoter/enhancer driven 6.3 kb human dystrophin cDNA (minigene) and tested in vitro for transgene expression. In these cultures, dystrophin mRNA was found to be proportionate with increasing MOI. Primary myoblast cultures derived from transgenic mdx mice expressing β-Gal under a muscle-specific promoter and showing high expression of the human mini-dystrophin transgene introduced by the adenoviral vector were grafted into anterior tibialis muscles of SCID mice. Ten and 24 days after transplantation, numerous muscle fibers expressing both human dystrophin and β-Gal were detected throughout the mouse muscles by immunohistochemistry using an antibody specific for human dystrophin. The presence of the human mini-dystrophin mRNA was also detected by RT-PCR. These results demonstrate that three essential conditions in autologous myoblast transplantation can be achieved: (1) in vivo survival of at least some of the transduced myoblasts; (2) efficient fusion of these cells with the host muscle fibers; and (3) the high expression of the dystrophin transgene in situ. Furthermore, this article provides a novel RT-PCR-based technique to quantify the human dystrophin minigene expression in vitro and in vivo.
- Subjects
MYOBLAST transfer therapy; DYSTROPHIN; DUCHENNE muscular dystrophy
- Publication
Gene Therapy, 1998, Vol 5, Issue 10, p1340
- ISSN
0969-7128
- Publication type
Article
- DOI
10.1038/sj.gt.3300753